Patent ID: 9504728
Filing Date: 2016-11-29
CPC Classification: A61K

Claim Text:
1. A pharmaceutical dosage form for oral administration comprising a sanglifehrin as active ingredient in which the sanglifehrin active ingredient is protected by provision of a layer of enteric coat, said enteric coat being stable in the acid environment of the stomach, and adapted to release the active ingredient in the higher pH environment of the small intestine, wherein the sanglifehrin is a compound of formula (I) or a pharmaceutically acceptable salt thereof: wherein: the moiety X R and wherein one or more carbon atoms of R or R and wherein one or more carbon atoms of an R or R R n represents a single or double bond, save that when n represents a double bond R R X with the proviso that where R including any tautomer thereof; and including a methanol adduct thereof in which a ketal is formed by the combination of the C-53 keto and the C-15 hydroxyl group and methanol.